Key Financial Performance (Q2 FY27)

Revenue Performance:

  • Quarterly revenue: ₹3,400 crores (37% YoY growth)
  • Half-yearly revenue (H1 FY27): ₹6,490 crores (38% YoY growth)

EBITDA Performance:

  • Quarterly EBITDA: ₹882 crores (30% YoY growth)
  • Network EBITDA margin (including Sahyadri): 26%
  • EBITDA margin (excluding Sahyadri): 27%
  • Half-yearly EBITDA: ₹1,631 crores (28% YoY growth)

Volume Metrics:

  • Inpatient volumes: 35% YoY growth
  • Outpatient volumes: 27% YoY growth
  • Average occupancy: 70% (vs 65% in Q1 FY27)
  • Length of stay: 2.8 days (industry-leading)
  • ARPOB (excluding Sahyadri): ₹77,000 per day (8% YoY growth)
  • Network ARPOB: ₹70,600 per day

Profitability:

  • PAT: ₹639 crores (H1 FY27)
  • PAT margin: 10% (H1 FY27)

Operational Highlights (H1 FY27)

Digital Revenue:

  • Digital contribution: 23% of overall revenue
  • E-pharmacy: 34,000 orders across 26 hospitals in 4 metros
  • Telehealth: 38,000 virtual consultations
  • Chatbot/Manipal AI: 24,000 interactions

Specialty Performance:

  • CONGO-R specialties (Cardiology, Oncology, Neurology, Gastroenterology, Orthopedics, Renal Sciences) contributed 64.2% of revenue
  • Oncology, neurology, and orthopedics led growth with 43% increase
  • Oncology revenue represents 12% of network revenue

Clinical Achievements:

  • Installed world's latest Da Vinci 5 robotic surgical system at Delhi Dwarka hospital
  • Introduced two-wheeler fleet first responder service in Bangalore
  • Patiala hospital introduced advanced robotic-assisted orthopedic surgery
  • Dhakuria Hospital performed first laser-guided renal artery angioplasty in Eastern India
  • Electronic City hospital performed South India's first 5-ALA fluorescence-guided brain tumor surgery
  • Goa Hospital performed state's first covered self-expandable metallic stent procedure

Sahyadri Hospitals Performance

Q2 FY27 Performance:

  • Revenue: ₹375 crores (13% QoQ growth)
  • EBITDA: ₹73 crores (26% QoQ growth)
  • EBITDA margin: 19.5% (200 bps improvement from Q1 FY27)
  • Digital revenue contribution: 11%

H1 FY27 Performance:

  • Revenue: ₹707 crores (18% YoY growth)
  • EBITDA: ₹131 crores (24% YoY growth)

Margin Progression:

  • FY26: 15.5%
  • Q1 FY27: 17.5%
  • Q2 FY27: 19.5%

New Facility Performance

Bangalore Greenfield Hospitals:

  • Kanakapura Hospital: 25% EBITDA margin (operating for 1+ year)
  • Yelahanka Hospital: 24% EBITDA margin (operating for <1 year)
  • Electronic City Hospital: EBITDA loss of ₹13 crores in Q2 (commissioned July/August 2026)

Expansion and Development Updates

Gurugram Project:

  • Secured 3.5-acre land on long-term lease
  • Phase 1: 500-bed multi-specialty tertiary care hospital
  • Construction completion expected in 3-4 years

Kinder Hospital Acquisition:

  • Completed acquisition of entire business operations and assets of Kinder Hospital, Bangalore
  • To be repositioned as neighborhood multi-specialty hospital in Whitefield area

Bed Addition Plans:

  • H2 FY27: 440-500 beds (greenfield and brownfield)
  • FY28: 100 beds (brownfield) + 100 beds from Kinder Hospital repositioning
  • Major additions expected from FY29 onwards including Mumbai facility

Regional Performance Insights

East India Cluster:

  • Volume impact due to transition from Swasthya Sathi to Ayushman Bharat scheme
  • Government business volumes de-grew by 17% in H1, but overall volumes positive due to cash/TPA growth
  • New oncology team joined Dhakuria Hospital, Kolkata
  • Annex building commissioned at Dhakuria Hospital (refurbished fire-affected AMRI building)

Karnataka Cluster:

  • Added approximately 150 beds each in Kanakapura and Yelahanka
  • Current occupancy around 100 beds in each new facility

Operational Strategy

Payer Mix:

  • Government business: 13-14% of revenue
  • Cash and TPA: ~80% of revenue (focus segment)
  • Strategy focused on attracting cash and TPA patients through clinical team additions and digital initiatives

Capacity Utilization:

  • Current occupancy: 70.7% in Q2 (from 65% in Q1)
  • Target occupancy: ~80% at aggregate level
  • No additional capex required to reach 80% occupancy
  • Modular approach to bed commissioning based on volume growth

Integration and Synergies

Sahyadri Integration:

  • Procurement synergies achieved
  • Digital revenue increased from 1% to 11%
  • 300 doctor profiles created online
  • Senior liver transplant team (42 clinicians) joined November 1, 2026
  • Insurance contract renegotiations ongoing under Sahyadri entity name
  • Rebranding to Manipal Hospitals and legal entity change in progress

Guidance and Outlook

Sahyadri Margin Target:

  • Expected to reach 23-24% EBITDA margin over 4-5 year period from acquisition
  • Current trajectory: 15.5% (FY26) → 17.5% (Q1) → 19.5% (Q2)

Market Expansion Strategy:

  • Continued focus on Tier 2/Tier 3 markets (Mysore, Mangalore, Patiala, Siliguri, Raipur)
  • Raipur greenfield (350 beds Phase 1) expected in Q4 FY27
  • Different approach for new markets (Mumbai, Raipur) vs densified markets (Bangalore)
  • Mumbai Juhu facility: 602 beds, will follow phased commissioning approach

Financial Management

Finance Costs:

  • Increased sequentially despite debt reduction due to debt repayment occurring on September 15, 2026
  • Full benefit of interest cost reduction expected from Q3 FY27

Corporate Strategy

Business Focus:

  • Core strength in tertiary and quaternary care
  • No plans to expand into diagnostics or pharmaceutical retail
  • Focus on out-of-hospital care including home care and digital health services
  • Geographic expansion beyond Karnataka (eastern India leadership, western India presence, Delhi/NCR expansion)